William P Schiemann

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Cancer Stem Cells

Long Noncoding Rna

Histone Deacetylase

Top Venues

Molecular cancer research : MCR

Science signaling

Molecular cancer therapeutics

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer R Diamond, Todd M Pitts, Dana Ungermannova, Christopher G Nasveschuk, Gan Zhang, Andrew J Phillips, Stacey M Bagby, Jessica Pafford, Betelehem W Yacob, Timothy P Newton, John J Tentler, Brian Gittleman, Sarah J Hartman, John A DeMattei, James D Winkler, Michael K Wendt, William P Schiemann, S Gail Eckhardt, Xuedong Liu, Anthony D Piscopio
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Molecular cancer therapeutics 21 (3) (2022)
Kimberly A Parker, Alex J Gooding, Saba Valadkhan, William P Schiemann
lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells. Molecular cancer research : MCR 19 (12) (2021)
Nathaniel J Robinson, Masaru Miyagi, Jessica A Scarborough, Jacob G Scott, Derek J Taylor, William P Schiemann
SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling. Science signaling 14 (689) (2021)
Nathaniel J Robinson, Chevaun D Morrison-Smith, Alex J Gooding, Barbara J Schiemann, Mark W Jackson, Derek J Taylor, William P Schiemann
SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness. Life science alliance 3 (4) (2020)